MEGACOM promout health
 
óêð
ðóñ
eng



 

 
Glianov / Hikma Pharmaceuticals


A third-generation sulfonylurea drug Indications: non-insulin-dependent II type diabetes mellitus, when diet, physical exercise and weight reduction alone are not adequate to control glycemia.

Dosage: The usual initial dose of Glianov is 1 mg once per day. If necessary the daily dose can be increased.

The dosage increase should be made in increments (1 mg – 2 mg – 3 mg- 4 mg – 6 mg) at 1-2 week intervals with regular monitor of blood sugar level.

A daily dose for patients with adequate compensation of diabetes mellitus usually is from 1 mg to 4 mg of Glianov.

Only some patients need to take 6 mg or more for adequate compensation of diabetes mellitus, the maximum daily dose may be 8 mg. The tablets are taken with plenty of water (not less than half a glass) before meals.

Drug dosage therapy is determined by a doctor taking into consideration a pace of life of a patient.

It is usually enough to take a daily dose once per day immediately before the first main meal. It is very important not to miss a meal after administration of Glianov.

11.06.10
Scientific-Practical Conference "Problems of Child Allergology and Rheumatology in Lviv »
20.05.10
XI Congress of otolaryngologists of Ukraine (May, 17-19th, 2010, Sudak) »
29.04.10
Megacom is marketing Oprazol 40mg #1 , lyophilised powder for infusion.  »
29.04.10
The XIIth international conference “Actual directions in neurology: present and future”  »
14.04.10
Round table in Kiev »







© 2004 «MEGACOM»
All right reserved


MEGACOM

Home  Company  Pressroom    Partners  Products  Guestbook  Contacts


Developed by design studio PEREVOROT
May, 2005